
The Untold Potential of Tempus AI: Navigating Market Dips and Healthcare Horizons
Tempus AI’s stock experienced an 8.37% dip, closing at $81.95, causing investor concern following a prior rally. The company’s partnership with the Institute for Follicular Lymphoma Innovation underscores its potential to transform disease treatment using AI technology. Tempus AI is developing a